Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMelanoma and MedlinePlus Genetics-related topics were removed from the related topics section, but the study details, eligibility criteria, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check20 days agoChange DetectedThe Publications note on PubMed-generated lists was updated to indicate automatic PubMed population, and the Revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the generic government funding/status notice from the page. Study content, eligibility criteria, and trial logistics remain unchanged.SummaryDifference0.3%
- Check35 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the Related Topics section.SummaryDifference0.1%
- Check42 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check56 days agoChange DetectedExpandedMedlinePlus Genetics topic: Melanoma added; no deletions.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.